+
+
Stay Informed
SOLUTIONS & PRODUCTS

From transcatheter and surgical valve therapies to structural interventions,

we’ve built a broad structural heart portfolio across the spectrum to restore health and improve quality of life for patients with structural heart disease.

YOUR PARTNER OF CHOICE
FOR STRUCTURAL HEART SOLUTIONS

Abbott offers a broad portfolio of structural heart solutions for an array of conditions. We invest in creating innovative technologies and advancing science, with the ultimate goal of helping patients achieve better health and improved quality of life. With our legacy of innovation, product diversity, safety, and performance, Abbott is your partner for structural heart therapies.

Some of the ways Abbott demonstrates its leadership in the industry include:

  • Established leader in transcatheter edge-to-edge repair (TEER)* with MitraClipTM1
  • Offering TriClipTM, the first and only TEER device, to date, designed specifically for the tricuspid valve
  • Offering among the broadest occluder portfolios, with 20+ years of leadership1
  • Demonstrating exceptional hemodynamics with tissue valves, and an impressive 40-year legacy with mechanical valves
  • Providing outstanding & competitive clinical outcomes physicians expect from the latest generation TAVI system

150K+

patients treated
 

Established leader in
transcatheter mitral valve repair
with MitraClipTM 1

20+

years of leadership
in occluders

We offer a broad portfolio
with PFO, LAA, PDA, septal,
and muscular VSD occluders

40

year legacy
 

We have an impressive 40-year legacy with mechanical valves and have demonstrated exceptional hemodynamics with tissue valves


*TEER is also referred to as TMVr (transcatheter mitral valve repair)

Transcatheter mitral valve repair therapy

TRANSCATHETER VALVE SOLUTIONS

BUILT TO HELP
PATIENTS RECLAIM
THEIR LIVES

Our minimally invasive transcatheter solutions are proven to safely, effectively repair or replace heart valves for patients and deliver excellent outcomes.

Explore Transcatheter Valve Solutions

SURGICAL VALVE SOLUTIONS

DESIGNED TO REBUILD HEALTHIER HEARTS

Our comprehensive surgical valve portfolio delivers long-term durability and performance, exceptional hemodynamics, and streamlined implantability.

Explore SURGICAL VALVE SOLUTIONS

Surgical valve solutions
Surgical valve solutions

SURGICAL VALVE SOLUTIONS

DESIGNED TO REBUILD HEALTHIER HEARTS

Our comprehensive surgical valve portfolio delivers long-term durability and performance, exceptional hemodynamics, and streamlined implantability.

Explore SURGICAL VALVE SOLUTIONS

STRUCTURAL INTERVENTIONS

BUILT FOR THE AGES.
DESIGNED FOR
COMPLETE CLOSURE.1

Our occluders are built to close an opening in patients’ hearts—saving and restoring lives by providing closure with confidence.

Explore structural interventionS

Structural intervention, occluder for stroke risk reduction
Structural intervention, occluder for stroke risk reduction

STRUCTURAL INTERVENTIONS

BUILT FOR THE AGES.
DESIGNED FOR
COMPLETE CLOSURE.1

Our occluders are built to close an opening in patients’ hearts—saving and restoring lives by providing closure with confidence.

Explore structural interventionS

Explore the interactive heart model below to learn more about our products and solutions across the structural heart spectrum.

Mitral Regurgitation

A condition in which the mitral valve does not close completely during contraction of the left ventricle, causing blood to leak backward into the left atrium.
Click on a product name to learn more about our therapy solutions

  • MitraClipTM Therapy

    MitraClipTM Therapy is a minimally invasive TMVr therapy that delivers a treatment option for select patients with mitral regurgitation who would otherwise go untreated.*
    *TMVr is also referred to as (Transcatheter edge-to-edge repair)
    MitraClip Therapy
    Learn More

  • EpicTM Mitral Stented Tissue Valve

    The EpicTM Mitral stented tissue valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic mitral heart valve.
    Epic™ Mitral Stented Tissue Valve
    Learn More

  • TendyneTM TMVR

    TendyneTM Transcatheter Mitral Valve Replacement offers select patients who have symptomatic, significant mitral regurgitation (≥ grade 3), a new option for safe and effective valve replacement.
    Tendyne™ TMVI
    Learn More
EpicTM MitralMitraClipTMTendyneTM
×

Aortic Stenosis

A narrowing of the aortic valve, which reduces or blocks blood flow from the left ventricle to the aorta.
Click on a product name to learn more about our therapy solutions

  • PorticoTM Valve

    The PorticoTM with FlexNavTM TAVI system is a minimally invasive treatment for patients with aortic stenosis.
    Abbott Portico with FlexNav TAVI system
    Learn More

  • EpicTM Supra Stented Tissue Valve

    The EpicTM Supra stented tissue valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve.
    Epic Supra stented tissue valve
    Learn More

  • RegentTM MHV

    The RegentTM mechanical heart valve is intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic valve.
    Regent MHV
    Learn More
PorticoTMEpicTM SupraRegentTM
×

Stroke Risk Reduction

Interventions intended to prevent thrombus formation include percutaneous closure of the left atrial appendage (LAA) and the patent foramen ovale (PFO).
Click on a product name to learn more about our therapy solutions

  • AmplatzerTM AmuletTM LAA Occluder

    A percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in suitable patients with nonvalvular atrial fibrillation.
    Amplatzer Amulet occluder for atrial fibrillation
    Learn More

  • AmplatzerTM TalismanTM PFO Occluder

    Designed for patent foramen ovale (PFO) closure, the AmplatzerTM TalismanTM PFO Occluder reduces the risk of recurrent ischemic stroke.
    Amplatzer™ Talisman™ PFO occluder
    Learn More
AmplatzerTM AmuletTM LAA OccluderAmplatzerTM TalismanTM PFO Occluder
×

Congenital defects

Congenital heart defects can involve the walls of the heart, the heart valves, and arteries and veins near the heart, disrupting normal blood flow.
Click on a product name to learn more about our therapy solutions

  • AmplatzerTM Septal Occluder

    A percutaneous transcatheter device for patients requiring atrial septal defect (ASD) closure.
    Amplatzer Septal occluder
    Learn More

  • AmplatzerTM VSD Occluder

    Ventricular septal defects (VSDs) are the most common congenital heart defect, and AmplatzerTM Muscular VSD Occluders provide minimally invasive treatment options.
    Amplatzer VSD occluder
    Learn More
AmplatzerTM Septal OccluderAmplatzerTM VSD Occluder
×

Tricuspid Regurgitation

A condition in which the tricuspid valve’s leaflets (or flaps) do not close properly, causing blood to flow backward into the right atrium.
Click on a product name to learn more about our therapy solutions

  • TriClipTM Therapy

    TriClipTM Transcatheter Edge-to-Edge Repair is a minimally invasive, non-surgical treatment option for severe, symptomatic tricuspid regurgitation patients who are at a high risk for surgery.
    TriClip™
    Learn More
TriClipTM
×
© 2023 Abbott. All rights reserved. MAT-2200917 v3.0 | Item approved for OUS use only.

MAT-2000632 v6.0 | Item approved for OUS use only.

References
  1. Data on file at Abbott.
Abbott Logo

Follow Abbott

Copyright © 2024 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: Product(s) are intended for use by or under the direction of a physician. Prior to use, reference to the Instructions for Use, inside the product carton (when available) or at www.eifu.abbott for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v18.0 | Item approved for OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

U.S. Health Care Professionals International Health Care Professionals

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel
+